Sosei
IPOAbout
Sosei Group Corporation (now rebranded as Nxera Pharma) is a Tokyo-based international biopharmaceutical company with expertise in drug discovery and development. The company is known for its GPCR structure-based drug design platform through its Heptares subsidiary.
Summary
Sosei is a Biotech company based in Tokyo, Japan.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2004
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.